Positive and negative psychotropic effects of levetiracetam

[1]  A. Aldenkamp,et al.  Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison , 2008, Seizure.

[2]  R. Leroy,et al.  Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy , 2007, Neurology.

[3]  A. Schulze-Bonhage,et al.  Levetiracetam reduces frequency and duration of epileptic activity in patients with refractory primary generalized epilepsy , 2006, Seizure.

[4]  A. Fogarasi,et al.  [Experience with levetiracetam in childhood epilepsy]. , 2006, Ideggyogyaszati szemle.

[5]  Josemir W Sander,et al.  The impact of levetiracetam on challenging behavior , 2006, Epilepsy & Behavior.

[6]  Raffaele Canger,et al.  Levetiracetam: An improvement of attention and of oral fluency in patients with partial epilepsy , 2006, Epilepsy Research.

[7]  C. Helmstaedter,et al.  EpiTrack: Tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy , 2005, Epilepsy & Behavior.

[8]  G. Bergey.  Evidence‐based Treatment of Idiopathic Generalized Epilepsies with New Antiepileptic Drugs , 2005, Epilepsia.

[9]  I. Tuxhorn,et al.  Levetiracetam in children with refractory epilepsy: A multicenter open label study in Germany , 2005, Seizure.

[10]  S. Berkovic,et al.  Efficacy and safety of levetiracetam 1000–3000mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study , 2005, Epilepsy Research.

[11]  M. Brodie,et al.  Levetiracetam for people with mental retardation and refractory epilepsy , 2004, Epilepsy & Behavior.

[12]  P. Smith,et al.  Levetiracetam as add-on therapy in generalised epilepsies , 2004, Seizure.

[13]  M. Tomka-Hoffmeister,et al.  Efficacy and tolerability of levetiracetam in patients with therapy-resistant epilepsy and learning disabilities , 2004, Seizure.

[14]  T. Walczak,et al.  Discontinuation of levetiracetam because of behavioral side effects , 2003, Neurology.

[15]  C. Elger,et al.  Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases , 2003, Epilepsy & Behavior.

[16]  J. Cramer,et al.  Tolerability of levetiracetam in elderly patients with CNS disorders , 2003, Epilepsy Research.

[17]  Josemir W Sander,et al.  Psychiatric adverse events during levetiracetam therapy , 2003, Neurology.

[18]  J. Cramer,et al.  Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam , 2003, Epilepsy & Behavior.

[19]  T. Rugino,et al.  Levetiracetam in Autistic Children: An Open-Label Study , 2002, Journal of developmental and behavioral pediatrics : JDBP.

[20]  C. Helmstaedter.  Behavioral Aspects of Frontal Lobe Epilepsy , 2001, Epilepsy & Behavior.

[21]  E S Barratt,et al.  Psychometric properties of an Italian version of the Barratt Impulsiveness Scale-11 (BIS-11) in nonclinical subjects. , 2001, Journal of clinical psychology.

[22]  N. Lobaugh,et al.  Piracetam therapy does not enhance cognitive functioning in children with down syndrome. , 2001, Archives of pediatrics & adolescent medicine.

[23]  Simon Shorvon,et al.  Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial Seizures , 2000 .

[24]  J. Cramer,et al.  Effect of Levetiracetam on Epilepsy‐Related Quality of Life , 2000, Epilepsia.

[25]  R. Beran,et al.  Aggressive Behaviour in Intellectually Challenged Patients with Epilepsy Treated with Lamotrigine , 1998, Epilepsia.

[26]  J. Patton,et al.  Factor structure of the Barratt impulsiveness scale. , 1995, Journal of clinical psychology.

[27]  A. Aldenkamp,et al.  Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[28]  Sonja Juliane Glogau.  Validierung des "Fragebogens zur Persönlichkeit bei zerebralen Erkrankungen" (FPZ) an einer Stichprobe von Epilepsiepatienten und Gesunden , 2006 .

[29]  B. Abou-Khalil.  Benefit-Risk Assessment of Levetiracetam in the Treatment of Partial Seizures , 2005, Drug safety.

[30]  P. Patsalos.  Levetiracetam: pharmacology and therapeutics in the treatment of epilepsy and other neurological conditions , 2004 .